122 related articles for article (PubMed ID: 11570085)
1. Garlic supplements found to lower saquinavir levels.
TreatmentUpdate; 2001; 12(12):17-8. PubMed ID: 11570085
[No Abstract] [Full Text] [Related]
2. Garlic reduces saquinavir blood levels 50%; may affect other drugs.
James JS
AIDS Treat News; 2001 Dec; (375):2-3. PubMed ID: 11810949
[No Abstract] [Full Text] [Related]
3. Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.
Maserati R; Villani P; Cocchi L; Regazzi MB
AIDS; 1998 May; 12(7):815-6. PubMed ID: 9619815
[No Abstract] [Full Text] [Related]
4. Garlic supplements can impede HIV medication.
J Am Coll Surg; 2002 Feb; 194(2):251. PubMed ID: 11848645
[No Abstract] [Full Text] [Related]
5. NIH studies link between saquinavir and garlic pills.
AIDS Alert; 2002 Feb; 17(2):26. PubMed ID: 11862747
[No Abstract] [Full Text] [Related]
6. Plasma and cerebrospinal fluid saquinavir concentrations in patients receiving combination antiretroviral therapy.
Moyle GJ; Sadler M; Buss N
Clin Infect Dis; 1999 Feb; 28(2):403-4. PubMed ID: 10064262
[No Abstract] [Full Text] [Related]
7. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
Klaus BD; Grodesky MJ
Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
[No Abstract] [Full Text] [Related]
8. Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
Merry C; Mulcahy F; Barry M; Gibbons S; Back D
AIDS; 1997 Feb; 11(2):268-9. PubMed ID: 9030388
[No Abstract] [Full Text] [Related]
9. Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
Michelet C; Ruffault A; Sébille V; Arvieux C; Jaccard P; Raffi F; Bazin C; Chapplain JM; Chauvin JP; Dohin E; Cartier F; Bellissant E
Antimicrob Agents Chemother; 2001 Dec; 45(12):3393-402. PubMed ID: 11709314
[TBL] [Abstract][Full Text] [Related]
10. From grapefruit juice to ritonavir.
TreatmentUpdate; 2001; 12(12):5-6. PubMed ID: 11570093
[No Abstract] [Full Text] [Related]
11. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
12. Garlic supplements can impede HIV medication.
Sussman E
AIDS; 2002 Jun; 16(9):N5. PubMed ID: 12090243
[No Abstract] [Full Text] [Related]
13. Combination study of Invirase and Norvir starting.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633
[No Abstract] [Full Text] [Related]
14. Garlic supplements and saquinavir.
Borek C
Clin Infect Dis; 2002 Aug; 35(3):343. PubMed ID: 12115105
[No Abstract] [Full Text] [Related]
15. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.
Hugen PW; Verweij-van Wissen CP; Burger DM; Wuis EW; Koopmans PP; Hekster YA
J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):139-49. PubMed ID: 10360433
[TBL] [Abstract][Full Text] [Related]
16. Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.
van der Lugt J; Gorowara M; Avihingsanon A; Burger D; Ananworanich J; Sringam K; Kerr S; Wit F; Lange J; Ruxrungtham K
AIDS; 2009 Jun; 23(9):1176-9. PubMed ID: 19451794
[TBL] [Abstract][Full Text] [Related]
17. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J;
Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443
[TBL] [Abstract][Full Text] [Related]
18. The effect of garlic supplements on the pharmacokinetics of saquinavir.
Piscitelli SC; Burstein AH; Welden N; Gallicano KD; Falloon J
Clin Infect Dis; 2002 Jan; 34(2):234-8. PubMed ID: 11740713
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats.
Shibata N; Kageyama M; Kishida T; Kimura K; Yoshikawa Y; Kuwahara T; Toh J; Shirasaka T; Takada K
Biopharm Drug Dispos; 2003 Nov; 24(8):335-44. PubMed ID: 14595702
[TBL] [Abstract][Full Text] [Related]
20. [Evidence-based therapeutic drug monitoring for saquinavir].
Muret P; Solas C;
Therapie; 2011; 66(3):207-12. PubMed ID: 21819804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
